Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 62.4;granulocytes: 114.1;Hofbauer cells: 92.9;Kupffer cells: 108.4;Macrophages: 93.2;monocytes: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"lymphoma: 36.7;pancreatic cancer: 15.0"	"Adipose subcutaneous - Macrophages, Breast - Breast glandular cells, Colon - Macrophages, Liver - Neutrophils, Skeletal muscle - Macrophages, Thyroid - Macrophages"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 19: Macrophages - Innate immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"
CDKN2D	"INK4D, p19"	ENSG00000129355	"Cyclin dependent kinase inhibitor 2D"	P55273	19	10566460-10569059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 283.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 105.6;monocytes: 100.6;NK-cells: 131.7;Spermatocytes: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Neutrophils, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011201, HPA043546"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 4: Platelets - Platelet activation"	Nucleoplasm	Cytosol	"CAB011201: AB_261049, HPA043546: AB_2678545"	"unprognostic (3.08e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.55e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-3)"	"unprognostic (9.90e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 101.7;placenta: 107.3"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 203.5;Kupffer cells: 184.5;Langerhans cells: 426.8;Macrophages: 271.2;monocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2322.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2322.4"	"Cancer enriched"	"Detected in some"	5	"Leukemia: 31.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Testis - Macrophages, Thyroid - Macrophages"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		46000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 69: Macrophages - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635185	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 207.8;lung: 86.5;lymphoid tissue: 141.1"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 119.3;Kupffer cells: 281.5;Langerhans cells: 80.3;Macrophages: 146.4;monocytes: 313.7;NK-cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	85	"Leukemia: 19.7;lymphoma: 37.8;Myeloma: 19.7"	"Adipose subcutaneous - Macrophages, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skin - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enriched"	"Detected in some"	9	"monocytes: 410.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Group enriched"	"Detected in some"	4	"Bladder cancer: 2.7;Leukemia: 2.7;liver cancer: 2.2"	"Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Testis - Early spermatids, Testis - Late spermatids, Thyroid - Neutrophils"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 325.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 242.5;Hofbauer cells: 146.5;Kupffer cells: 248.4;Macrophages: 157.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 327.4;neutrophil: 864.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 864.2"	"Low cancer specificity"	"Detected in all"			"Liver - Neutrophils, Lung - Neutrophil_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 33: Macrophages - Degranulation"	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.0;heart muscle: 26.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Excitatory neurons: 61.3;Hofbauer cells: 29.2;Kupffer cells: 52.5;Macrophages: 43.8;monocytes: 48.8;Smooth muscle cells: 32.0"	"Group enriched"	"Detected in many"	5	"melanoma: 2.9;renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 134.4;neutrophil: 161.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 161.7;monocytes: 51.6"	"Cancer enhanced"	"Detected in some"		"Leukemia: 9.4;Myeloma: 4.9"	"Liver - Neutrophils, Lung - Neutrophil_2, Stomach - Parietal cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"			"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 38.2;dendritic cells: 56.2;granulocytes: 92.9;Langerhans cells: 33.2;NK-cells: 47.8;Schwann cells: 26.6;T-cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Liver - Neutrophils"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 50: L-1236 & L-428 - Unknown function"	"Cluster 1: T-cells - Immune response"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in some"		"granulocytes: 57.7;Hofbauer cells: 71.9;Langerhans cells: 143.3;Macrophages: 114.2;Microglial cells: 54.7;monocytes: 272.2;NK-cells: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.4;lymphoma: 9.2"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Liver - Neutrophils, Skeletal muscle - Neutrophils, Thyroid - T-cells"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871, CAB080214"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 75: Myeloid cells - Innate immune response"	"Vesicles, Plasma membrane"		"CAB004458: AB_626859, CAB072871: AB_2665723, CAB080214: , HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.0;lymphoid tissue: 49.9"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 88.5;Kupffer cells: 118.4;Macrophages: 81.0;monocytes: 139.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 44.8;monocytes: 15.4"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Skin - Macrophages, Thyroid - Neutrophils"									HPA026985			Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane"	Cytosol	"HPA026985: "	"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 247.3;monocytes: 299.9;NK-cells: 249.6;Schwann cells: 297.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Neutrophils, Liver - Neutrophils"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 75: Myeloid cells - Innate immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 263.7;Kupffer cells: 154.3;Langerhans cells: 170.6;Macrophages: 199.3;monocytes: 262.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"liver cancer: 63.9;lymphoma: 45.9"	"Adipose subcutaneous - Macrophages, Breast - Macrophages, Colon - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Prostate - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 19: Macrophages - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793741-53824394	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.3"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 6.7;Kupffer cells: 14.4;Macrophages: 7.8;monocytes: 9.9"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;classical monocyte: 18.1;eosinophil: 23.2;neutrophil: 29.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 56.9;monocytes: 18.1"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.8"	"Adipose visceral - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042981	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"			"HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669049-7670455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 247.2"	"Group enriched"	"Detected in some"	9	"Hofbauer cells: 174.6;Kupffer cells: 78.9;Macrophages: 68.7;monocytes: 52.7"	"Group enriched"	"Detected in many"	4	"lung cancer: 2.6;pancreatic cancer: 4.8;thyroid cancer: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 170.4;intermediate monocyte: 91.7;myeloid DC: 118.7;non-classical monocyte: 47.4"	"Group enriched"	"Detected in many"	11	"dendritic cells: 118.7;monocytes: 170.4"	"Cancer enriched"	"Detected in single"	147	"Leukemia: 68.2"	"Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Neutrophils, Prostate - Macrophages, Thyroid - Neutrophils"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	1200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 19: Macrophages - Innate immune response"				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 84.5;Excitatory neurons: 90.1;Inhibitory neurons: 93.5;Oligodendrocyte precursor cells: 37.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 4.8;skin cancer: 3.9"	"Colon - Colon enteroendocrine cells, Kidney - Macrophages, Liver - Neutrophils, Testis - Early spermatids, Testis - Late spermatids"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 37: Neurons - Neuronal signaling"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"
SBNO2	"FLJ00173, KIAA0963, Sno, Stno"	ENSG00000064932	"Strawberry notch homolog 2"	Q9Y2G9	19	1107637-1174268	"Predicted intracellular proteins"	"Differentiation, Osteogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Low cancer specificity"	"Detected in all"			"Liver - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041867	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 66: Endothelial cells - Angiogenesis"			"HPA041867: AB_2677715"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (8.48e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (7.98e-8)"	"unprognostic (1.34e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.88e-1)"
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 150.4;lymphoid tissue: 231.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 219.7;dendritic cells: 372.3;Kupffer cells: 151.8;Macrophages: 79.3;monocytes: 107.9;NK-cells: 89.0;T-cells: 114.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 31.9;lymphoma: 22.0;Myeloma: 15.0"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol		NA	NA		4700000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 2: T-cells - T-cell receptor"	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"prognostic favorable (3.76e-4)"	"prognostic favorable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.7;lymphoid tissue: 12.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 5.4;Kupffer cells: 10.7;Macrophages: 3.6;monocytes: 3.3"	"Cancer enriched"	"Detected in single"	5	"urothelial cancer: 1.7"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"neutrophil: 152.5;non-classical monocyte: 49.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 152.5;monocytes: 49.3"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 3.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2"									"HPA009085, CAB024900"	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 33: Macrophages - Degranulation"			"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	10	"dendritic cells: 36.0;Hofbauer cells: 29.7;Kupffer cells: 70.2;Macrophages: 32.0;monocytes: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 18.2;Sarcoma: 15.1;thyroid cancer: 22.7"	"Adipose subcutaneous - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2716.6;granulocytes: 3383.8;Hofbauer cells: 2543.8;Langerhans cells: 8327.6;Macrophages: 2923.0;monocytes: 5983.1;NK-cells: 3789.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cancer enhanced"	"Detected in many"		"Leukemia: 1138.5;Myeloma: 481.5"	"Breast - Endothelial cells, Heart muscle - Endothelial cells, Liver - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 75: Myeloid cells - Innate immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 126.1;Langerhans cells: 388.2;Macrophages: 154.2;monocytes: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cancer enhanced"	"Detected in many"		"lymphoma: 7.3"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Colon - Endothelial cells, Liver - Neutrophils, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 75: Myeloid cells - Innate immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 91.8;Langerhans cells: 49.1;Macrophages: 109.0;monocytes: 207.7;Mucus glandular cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 14.0;Leukemia: 10.5"	"Adipose subcutaneous - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Stomach - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 75: Myeloid cells - Innate immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.6;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 61.1;Hofbauer cells: 26.4;Kupffer cells: 43.0;Macrophages: 37.9;monocytes: 30.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 477.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 477.4"	"Cancer enriched"	"Detected in many"	6	"lymphoma: 24.5"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Testis - Macrophages, Thyroid - Neutrophils"					"Low region specificity"	"Detected in some"									NA	NA		240000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 33: Macrophages - Degranulation"				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"